Sandy Walsh News
-
Paulson & Co. executives were sued for alleged conflicts in the handling of intellectual property assets in the bankruptcy of a group of resorts including Miami’s Doral golf course, where Tiger Woods won his 76th PGA Tour event last month.
-
Bayer AG sued the U.S. Food and Drug Administration seeking to block sales of a generic form of the livestock antibiotic Baytril 100 being sold by competitor Norbrook Laboratories Ltd.
-
Valinda Parrish talks to her 60- year-old husband like a doting mother speaks to a child. “I am going to go outside for a little bit,” she tells him. “Use your horn if you need me.”
-
The Food and Drug Administration hasn’t approved Ranbaxy Laboratories Ltd.’s generic version of Pfizer Inc.’s $10.7 billion Lipitor cholesterol pill, Sandy Walsh, a spokeswoman for the agency, said.
-
Watson Pharmaceuticals Inc. may begin immediately marketing a generic version of Takeda Pharmaceutical Inc.’s diabetes drug Actos, a federal judge ruled, handing the U.S. Food and Drug Administration a defeat.
-
Pfizer Inc.’s $10.7 billion cholesterol pill Lipitor gained a rival today after Ranbaxy Laboratories Ltd. was cleared by U.S. regulators to sell copies of the drug.
-
Johnson & Johnson ’s Risperdal and Eli Lilly & Co. ’s Zyprexa are among more than 20 antipsychotic drugs that U.S. regulators said may pose risks to newborns when taken by mothers during pregnancy.
-
Two companies aim to do for the health-care industry what Morningstar Inc. does for stocks and Carfax Inc. for vehicles: provide consumers with ratings for drugs and medical devices.
-
CBOE Holdings Inc. and NYSE Euronext may create venues for derivatives that now trade over the counter to capitalize on proposed rules designed to bring more transparency to the $583 trillion market.
-
Endo Health Solutions Inc. lost a bid to stop competitors from selling a generic version of its painkiller drug Opana ER over claims that the drug poses a risk to the public.
|
|
Most Popular on Bloomberg
|
| |
Rate this Page